SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001019687-15-004252
Filing Date
2015-11-19
Accepted
2015-11-19 16:21:49
Documents
12
Period of Report
2015-09-30
Filing Date Changed
2015-11-19

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vglife_10q-093015.htm 10-Q 406021
2 CONSULTING AGREEMENT vgls_ex10178.htm EX-10.178 54478
3 CONSULTING AGREEMENT vgls_ex10181.htm EX-10.181 53074
4 CERTIFICATION vglife_10q-ex3101.htm EX-31.1 7930
5 CERTIFICATION vglife_10q-ex3102.htm EX-31.2 7818
6 CERTIFICATION vglife_10q-ex3201.htm EX-32.1 4132
  Complete submission text file 0001019687-15-004252.txt   1479042

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vgls-20150930.xml EX-101.INS 118976
8 XBRL SCHEMA FILE vgls-20150930.xsd EX-101.SCH 15687
9 XBRL CALCULATION FILE vgls-20150930_cal.xml EX-101.CAL 30942
10 XBRL DEFINITION FILE vgls-20150930_def.xml EX-101.DEF 34555
11 XBRL LABEL FILE vgls-20150930_lab.xml EX-101.LAB 116997
12 XBRL PRESENTATION FILE vgls-20150930_pre.xml EX-101.PRE 88976
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26875 | Film No.: 151243887
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1